Cargando…
Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis
PURPOSE: Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties. We assessed the benefits and harms of AT III in critically ill patients. METHODS: We searched from inception to 27 August 2015 in CENTRAL, MEDLINE, EMBASE, CAB, BIOSIS and CINAHL. We included randomized control...
Autores principales: | Allingstrup, Mikkel, Wetterslev, Jørn, Ravn, Frederikke B., Møller, Ann Merete, Afshari, Arash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095103/ https://www.ncbi.nlm.nih.gov/pubmed/26862016 http://dx.doi.org/10.1007/s00134-016-4225-7 |
Ejemplares similares
-
Milrinone for cardiac dysfunction in critically ill adult patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
por: Koster, Geert, et al.
Publicado: (2016) -
Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis
por: Volbeda, M., et al.
Publicado: (2015) -
Dopamine in critically ill patients with cardiac dysfunction: A systematic review with meta‐analysis and trial sequential analysis
por: Hiemstra, Bart, et al.
Publicado: (2018) -
Antithrombin III levels in critically ill surgical patients: do they correlate with VTE?
por: Bhatti, Umar F, et al.
Publicado: (2023) -
Haloperidol for the treatment of delirium in critically ill patients: an updated systematic review with meta-analysis and trial sequential analysis
por: Andersen-Ranberg, Nina Christine, et al.
Publicado: (2023)